Skip to main content
Swing Capital

Ajooni Biotech Ltd

NSE: AJOONI

Incorporated in 2010, Ajooni Biotech Ltd is a PURE VEG. animal health care solutions company. It is a significant player in the animal feed and aquaculture sectors.[1]

₹4.07
52W: ₹3.55 — ₹6.6
PE 14.3 · Book ₹5.29 · -23% vs book
Market Cap₹70.1 Cr
Stock P/E14.3Price to Earnings
ROCE6.91%Return on Capital
ROE5.15%Return on Equity
Div. Yield0%Face Value ₹2

Strengths

  • +Stock is trading at 0.77 times its book value
  • +Company is expected to give good quarter
  • +Debtor days have improved from 70.5 to 51.7 days.

Weaknesses

  • −Though the company is reporting repeated profits, it is not paying out dividend
  • −Promoter holding is low: 26.9%
  • −Company has a low return on equity of 4.87% over last 3 years.
  • −Earnings include an other income of Rs.2.46 Cr.
  • −Promoter holding has decreased over last 3 years: -9.50%

Shareholding Pattern

Promoters26.89%
FIIs0%
DIIs0%
Public73.11%
CategoryJun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Promoters26.89%26.89%26.89%26.89%26.89%26.89%26.89%26.89%
FIIs0%0.29%▲0.30.18%▼0.10%▼0.20%0%0%0%
DIIs0%0%0%0%0%0%0%0%
Public73.11%72.82%▼0.372.92%▲0.173.11%▲0.273.11%73.11%73.11%73.11%

Financial Statements

MetricSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Sales19.4820.0519.5825.6625.7234.0329.2731.2731.7458.75
Expenses18.8520.717.9924.724.9533.128.2630.5630.2455.72
Operating Profit0.63-0.651.590.960.770.931.010.711.53.03
OPM %3.23%-3.24%8.12%3.74%2.99%2.73%3.45%2.27%4.73%5.16%
Net Profit0.40.440.910.470.620.731.540.780.931.65
EPS ₹0.020.030.050.030.040.040.090.050.050.1

AI Insights

Revenue Trend

TTM revenue at ₹151Cr, up 31.3% YoY. OPM at 4%.

Debt Position

Borrowings at ₹9Cr. Debt-to-equity ratio: 0.16x. Healthy balance sheet.

Capex Cycle

CWIP at ₹11Cr (100% of fixed assets). Significant capex underway — growth runway building.

Institutional Flow

DIIs: 0% (+0.00pp change). FIIs: 0% (+0.00pp change). Promoters hold 26.89%.

Margin & Efficiency

ROCE improving from 0% (Mar 2014) to 7% (Mar 2025). Working capital days: 160.

Valuation

PE 14.3x with 6.91% ROCE. Price is -23% above book value of ₹5.29. Dividend yield: 0%.

Recent Announcements